Roche Venture Fund | VCINVEST DATA

	Country	Date	Notes
Horizon Discovery Ltd	United Kingdom	3 Jun 2013 16 Jan 2012	Series C Round participant. Active
Opsona Therapeutics Ltd Innate immune drug development company	Ireland	29 Apr 2013	Series C Active
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer.	United States	10 Jun 2011	Series D
Nereus Pharmaceuticals Inc	United States	1 Aug 2007 1 Jun 2010	Series E
Inimex Pharmaceuticals Inc	Canada	1 Jun 2008	Series B
IRX Therapeutics Inc	United States		N/A
Halozyme Therapeutics Inc Biopharmaceutical company developing & commercializing products targeting the extracellular matrix.	United States		N/A
Aileron Therapeutics Inc Developing a breakthrough proprietary peptide technology platform	United States		N/A Active
Alnylam Pharmaceuticals Inc	United States		N/A
Intradigm Corp	United States		N/A
Addex Pharmaceuticals SA Switzerland-based drug company focused on CNS disorders	Switzerland		N/A Active
CytomX Therapeutics Developer of proteolytically-activated antibodies	United States		Series B
Conatus Pharmaceuticals Inc Biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer.	United States		N/A

Analytics